Software developers will still drive the core constructs of any given codebase, they will determine the algorithmic logic ...
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
Presented initial data from Phase 1b study suggesting GT-02287 has a disease-slowing effect consistent with the preclinical models in vivo and ...
Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster ...
Demis Hassabis has spent much of the past decade trying to unlock the secrets of the universe through artificial intelligence ...
Anumana, a leader in AI-powered cardiovascular diagnostics, today announced new groundbreaking clinical data presented at the American Heart Association (AHA) Scientific Sessions 2025. Among the ...
Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...
Homecare Homebase(SM) (HCHB), the leading software provider for home-based care, today announced the winners of its 2025 Customer Awards and ...
AtaiBeckley solidifies position as a global leader in transformative mental health therapies with a short psychedelic duration ...
Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...
Microbix’s CEO & President, Cameron Groome, commented “Microbix regrets any impacts of international cybercrime and is continuing to improve its IT security at all levels. We appreciate the ...
Year, and Adjusted EBITDA of $11.7 Million, up 34% Year-Over YearNine Month Revenue of $135.8 Million, up 11% Year-over-Year; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback